Age‐stratified reference intervals unlock the clinical potential of circulating cell‐free DNA as a biomarker of poor outcome for healthy individuals and patients with colorectal cancer

Circulating cell‐free DNA (cfDNA) has spurred much interest as a biomarker in oncology. However, inter‐ and intra‐individual cfDNA levels vary greatly. Consequently, in order to base clinical decisions on cfDNA measurements, normal reference intervals are essential to avoid that ordinary variation i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ørntoft, Mai‐Britt Worm, Jensen, Sarah Østrup, Øgaard, Nadia, Henriksen, Tenna Vesterman, Ferm, Linnea, Christensen, Ib Jarle, Reinert, Thomas, Larsen, Ole Halfdan, Nielsen, Hans Jørgen, Andersen, Claus Lindbjerg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Cancer Genetics and Epigenetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898909/
https://www.ncbi.nlm.nih.gov/pubmed/33320961
http://dx.doi.org/10.1002/ijc.33434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898909/
https://www.ncbi.nlm.nih.gov/pubmed/33320961
http://dx.doi.org/10.1002/ijc.33434

Ejemplares similares